1. Home
  2. IVDA vs GCTK Comparison

IVDA vs GCTK Comparison

Compare IVDA & GCTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Iveda Solutions Inc.

IVDA

Iveda Solutions Inc.

HOLD

Current Price

$0.28

Market Cap

2.9M

Sector

Technology

ML Signal

HOLD

Logo GlucoTrack Inc.

GCTK

GlucoTrack Inc.

HOLD

Current Price

$0.39

Market Cap

3.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IVDA
GCTK
Founded
2003
2001
Country
United States
United States
Employees
32
N/A
Industry
Computer Software: Prepackaged Software
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9M
3.0M
IPO Year
N/A
2011

Fundamental Metrics

Financial Performance
Metric
IVDA
GCTK
Price
$0.28
$0.39
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
391.6K
567.6K
Earning Date
05-12-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
2.65
Revenue
N/A
$589,462.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$0.15
Revenue Growth
N/A
N/A
52 Week Low
$0.22
$0.29
52 Week High
$2.58
$15.90

Technical Indicators

Market Signals
Indicator
IVDA
GCTK
Relative Strength Index (RSI) 39.19 29.44
Support Level $0.27 N/A
Resistance Level $0.35 $1.02
Average True Range (ATR) 0.04 0.08
MACD -0.01 -0.02
Stochastic Oscillator 6.58 17.64

Price Performance

Historical Comparison
IVDA
GCTK

About IVDA Iveda Solutions Inc.

Iveda Solutions Inc offers smart city technologies globally, offering advanced AI-driven video surveillance solutions and a robust suite of Internet of Things (IoT) platforms that power digital transformation for cities and commercial clients worldwide. The smart cities market, as well as the AI and IoT segments, are poised for significant growth in the coming years. The company offers AI-intelligent video search, smart utility, smart sensors, gateways, and trackers, and IoT platforms (Products).

About GCTK GlucoTrack Inc.

GlucoTrack Inc is a medical device company focused on the development of an implantable continuous blood glucose monitor (CBGM) for patients with Type 1 and Type 2 diabetes. The company is developing its Glucotrack CBGM system to provide continuous glucose monitoring using implantable sensor technology and is advancing the product through clinical studies and regulatory processes.

Share on Social Networks: